Thomas Flaten
Stock Analyst at Lake Street
(3.25)
# 958
Out of 5,090 analysts
34
Total ratings
36.11%
Success rate
8.32%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTHS Pelthos Therapeutics | Initiates: Buy | $50 | $26.57 | +88.18% | 1 | Dec 3, 2025 | |
| CNTB Connect Biopharma Holdings | Initiates: Buy | $9 | $2.40 | +275.00% | 1 | Dec 1, 2025 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $9 | $3.60 | +150.00% | 1 | Nov 13, 2025 | |
| EVAX Evaxion | Maintains: Buy | $6 → $11 | $5.25 | +109.52% | 3 | Oct 20, 2025 | |
| HROW Harrow | Maintains: Buy | $42 → $70 | $45.75 | +53.01% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $7.93 | +63.93% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $3.98 | +101.01% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $8.78 | +59.45% | 2 | Jul 18, 2025 | |
| AYTU Aytu BioPharma | Initiates: Buy | $8 | $2.22 | +260.36% | 1 | Jul 1, 2025 | |
| BDSX Biodesix | Maintains: Buy | $60 → $40 | $7.68 | +421.17% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $38.65 | -9.44% | 6 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $6.38 | +25.39% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $9.56 | -5.86% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.77 | +290.88% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $4.62 | +138.10% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $25.46 | -1.81% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $1.64 | +87,704.88% | 2 | Nov 17, 2022 |
Pelthos Therapeutics
Dec 3, 2025
Initiates: Buy
Price Target: $50
Current: $26.57
Upside: +88.18%
Connect Biopharma Holdings
Dec 1, 2025
Initiates: Buy
Price Target: $9
Current: $2.40
Upside: +275.00%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.60
Upside: +150.00%
Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6 → $11
Current: $5.25
Upside: +109.52%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $45.75
Upside: +53.01%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $7.93
Upside: +63.93%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $3.98
Upside: +101.01%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $8.78
Upside: +59.45%
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.22
Upside: +260.36%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $7.68
Upside: +421.17%
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $38.65
Upside: -9.44%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $6.38
Upside: +25.39%
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $9.56
Upside: -5.86%
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.77
Upside: +290.88%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.62
Upside: +138.10%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $25.46
Upside: -1.81%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $1.64
Upside: +87,704.88%